PH18211A - Long-acting matrix tablet formulations - Google Patents

Long-acting matrix tablet formulations

Info

Publication number
PH18211A
PH18211A PH29379A PH29379A PH18211A PH 18211 A PH18211 A PH 18211A PH 29379 A PH29379 A PH 29379A PH 29379 A PH29379 A PH 29379A PH 18211 A PH18211 A PH 18211A
Authority
PH
Philippines
Prior art keywords
long
tablet formulations
matrix tablet
acting matrix
acting
Prior art date
Application number
PH29379A
Other languages
English (en)
Inventor
Morgan Lee Beatty
Wayne Alan Boettner
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH18211A publication Critical patent/PH18211A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH29379A 1982-08-12 1983-08-10 Long-acting matrix tablet formulations PH18211A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/407,511 US4704284A (en) 1982-08-12 1982-08-12 Long-acting matrix tablet formulations

Publications (1)

Publication Number Publication Date
PH18211A true PH18211A (en) 1985-04-30

Family

ID=23612384

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29379A PH18211A (en) 1982-08-12 1983-08-10 Long-acting matrix tablet formulations

Country Status (17)

Country Link
US (1) US4704284A (es)
EP (1) EP0103387A3 (es)
JP (1) JPS5948415A (es)
KR (1) KR860000840B1 (es)
AU (1) AU546249B2 (es)
CA (1) CA1214391A (es)
DK (1) DK365883A (es)
EG (1) EG16065A (es)
ES (1) ES524892A0 (es)
FI (1) FI82186C (es)
GR (1) GR78921B (es)
GT (1) GT198303076A (es)
NO (1) NO169818C (es)
NZ (1) NZ205205A (es)
PH (1) PH18211A (es)
PT (1) PT77185B (es)
ZA (1) ZA835900B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729927B2 (ja) * 1983-04-09 1995-04-05 日研化学株式会社 テオフィリン徐放性製剤
IE58246B1 (en) * 1984-12-21 1993-08-11 Byk Gulden Lomberg Chem Fab Theophylline sustained release formulation
FR2585246A1 (fr) * 1985-07-26 1987-01-30 Cortial Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
US4837032A (en) * 1986-02-04 1989-06-06 Farval Ag Theophylline sustained release tablet
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
US4917892A (en) * 1988-06-28 1990-04-17 Temple University Encapsulated topical delivery system
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5364646A (en) * 1990-01-10 1994-11-15 Dr. Karl Thomae Gmbh Oral pharmaceutical forms of pimobendan
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
US20070082918A1 (en) * 1993-11-02 2007-04-12 Naftchi N E Neurologically active compounds and compounds with multiple activities
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
DE19631084A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
US6028929A (en) * 1997-11-14 2000-02-22 Tellabs Operations, Inc. Echo canceller employing dual-H architecture having improved non-linear echo path detection
US20020106408A1 (en) * 2000-12-01 2002-08-08 Johnatan Bacon Prolamin-based sustained-release compositions and delayed-onset compositions
IL163642A0 (en) * 2002-02-26 2005-12-18 Astrazeneca Ab Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
US20060093661A1 (en) * 2002-05-07 2006-05-04 Kapac, Llc Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
GB0317663D0 (en) * 2003-07-29 2003-09-03 Astrazeneca Ab Pharmaceutical composition
AU2004264958B2 (en) 2003-08-13 2010-04-15 Biocon, Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
MX2016000727A (es) 2013-07-19 2016-04-13 Boehringer Ingelheim Vetmed Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservante.
HUE056143T2 (hu) 2013-12-04 2024-01-28 Boehringer Ingelheim Vetmedica Gmbh Pimobendán javított gyógyászati készítményei
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
US3044938A (en) * 1955-07-01 1962-07-17 Sandoz Chemical Works Inc Sustained action pharmaceutical tablets
US2809917A (en) * 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical tablets
NL109293C (es) * 1955-12-22
US3039933A (en) * 1957-10-07 1962-06-19 Premo Pharmaceutical Lab Inc Ethyl cellulose-polyethylene glycol tablet matrix
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US2956926A (en) * 1958-09-23 1960-10-18 American Cyanamid Co Coated citric acid particles
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US2951792A (en) * 1959-11-18 1960-09-06 Smith Kline French Lab Sustained release pharmaceutical tablets
NL113366C (es) * 1961-02-24
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
NL297631A (es) * 1963-06-03
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3608063A (en) * 1969-08-15 1971-09-21 Gilbert S Banker Molecular drug entrapment process and compositions
US3632739A (en) * 1969-12-29 1972-01-04 Sandoz Ag Solid sustained release pharmaceutical preparation
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US4012498A (en) * 1974-03-27 1977-03-15 Sandoz, Inc. Sustained release tablet formulations
US3939259A (en) * 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
US4171363A (en) * 1977-02-22 1979-10-16 Bristol-Myers Company 1,2,3-Thiadiazole process
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
US4130647A (en) * 1977-07-08 1978-12-19 Pfizer Inc. Methods for treating congestive heart failure and ischemic heart disease
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
JPS5649314A (en) * 1979-07-05 1981-05-02 Yamanouchi Pharmaceut Co Ltd Lasting pharmaceutical composition having prolonged action and its preparation
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4248856A (en) * 1979-07-10 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
JPS56122311A (en) * 1980-02-29 1981-09-25 Eisai Co Ltd Lasting theophylline pharmaceutical composition

Also Published As

Publication number Publication date
KR840005661A (ko) 1984-11-15
PT77185B (en) 1986-07-11
ES8502333A1 (es) 1985-01-01
US4704284A (en) 1987-11-03
NO169818C (no) 1992-08-12
DK365883A (da) 1984-02-13
EP0103387A2 (en) 1984-03-21
ES524892A0 (es) 1985-01-01
FI832895A (fi) 1984-02-13
PT77185A (en) 1983-09-01
EG16065A (en) 1986-12-30
CA1214391A (en) 1986-11-25
KR860000840B1 (ko) 1986-07-09
GR78921B (es) 1984-10-02
JPS5948415A (ja) 1984-03-19
AU546249B2 (en) 1985-08-22
FI82186B (fi) 1990-10-31
DK365883D0 (da) 1983-08-11
NZ205205A (en) 1986-06-11
FI82186C (fi) 1991-02-11
AU1788683A (en) 1984-02-16
NO169818B (no) 1992-05-04
FI832895A0 (fi) 1983-08-11
GT198303076A (es) 1985-01-30
EP0103387A3 (en) 1984-12-12
NO832883L (no) 1984-02-13
ZA835900B (en) 1985-03-27

Similar Documents

Publication Publication Date Title
PH18211A (en) Long-acting matrix tablet formulations
GB8500639D0 (en) Fast-starting sustained release tablet
DE3378523D1 (en) Pharmaceutical formulations
GB8315489D0 (en) Stable pharmaceutical tablet
DE3269389D1 (en) Pharmaceutical formulations containing antimony
KE3814A (en) Pharmaceutical formulations
GB2098867B (en) Sustained release pharmaceutical composition
GB8311420D0 (en) Insulin formulations
GB2074028B (en) Pharmaceutical formulations
DE3466477D1 (en) Pharmaceutical formulations
GB8414123D0 (en) Pharmaceutical pellet
GB2121302B (en) Display tablets
AU87660S (en) Pharmaceutical tablet
IE831888L (en) Long-acting tablet formulations
ZA833692B (en) Pharmaceutical formulations
CA50538S (en) Pharmaceutical tablet
CA50537S (en) Pharmaceutical tablet
CA53690S (en) Tablet
CA53689S (en) Tablet
KE3863A (en) Pharmaceutical formulations containing antimony
AU87628S (en) Display tablet
AU87659S (en) Pharmaceutical tablet
GB8319759D0 (en) Pharmaceutical formulations
GB8316498D0 (en) Pharmaceutical formulations
GB8319760D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 12